Date:06-May-2024  Time: 12:20 AM
 
 
        
Biogen Pharmachem Industries Ltd
(Rs. In Crores)
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operating Income 0.002.471.620.000.95
Other Income 0.910.010.000.000.00
Total Income0.912.481.620.000.95
Interest & Financial Charges 0.000.000.000.000.00
Operating & Administrative Expenses 0.462.483.230.120.95
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Depreciation & Tax0.46-0.01-1.60-0.120.00
Depreciation0.000.000.000.000.00
Profit Before Tax0.46-0.01-1.60-0.120.00
Tax0.000.000.000.000.00
Profit After Tax0.46-0.01-1.60-0.120.00
Adjustment below net profit 0.000.000.001.590.00
P & L Balance brought forward-11.13-11.12-9.51-10.99-10.98
Appropriations 0.000.000.000.000.00
P & L Balance carried down-10.67-11.13-11.12-9.51-10.99
Equity Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)0.000.000.000.000.00
Earning Per Share (Rs.)0.010.00-0.020.000.00
Book Value0.840.830.830.850.83
Extraordinary Items 0.660.000.000.000.00
 
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com